Crispina Calsada | CFO |
Joseph Hagan | President, CEO & Director |
Yi Chen | H.C. Wainwright & Co. |
Good day, and welcome to the Regulus Therapeutics Inc.
First Quarter 2022 Conference Call. [Operator Instructions]. Please note, this event is being recorded. I would now like to turn the conference over to Cris Calsada, Chief Financial Officer.